SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-003061
Filing Date
2017-04-04
Accepted
2017-04-04 15:39:56
Documents
6
Period of Report
2017-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mdit8k.htm 8-K 23156
2 SETTLEMENT AGREEMENT ex10-1.htm EX-10.1 23295
3 SETTLEMENT AGREEMENT ex10-2.htm EX-10.2 17898
4 SETTLEMENT AGREEMENT ex10-3.htm EX-10.3 17718
5 IMAGE ex10-2000.jpg GRAPHIC 19900
6 IMAGE ex10-3001.jpg GRAPHIC 18245
  Complete submission text file 0001654954-17-003061.txt   136323
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)

IRS No.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-00935 | Film No.: 17737893
SIC: 3841 Surgical & Medical Instruments & Apparatus